Mizuho Maintains an Outperform Rating on Salesforce (CRM)

Salesforce Incorporated (NYSE:CRM) is one of the 12 oversold software stocks to invest in.

On February 17, Gregg Moskowitz of Mizuho Securities maintained his Outperform rating on Salesforce Incorporated (NYSE:CRM). He lowered the price target from $340 to $280, which still yields close to 48% upside.

Moskowitz’s downward revision is part of Mizuho’s price target revisions across the enterprise software segment. The firm stated:

 “Due to AI disruption fears, sentiment across software is nothing short of horrible at the moment.”

However, Mizuho Securities also noted that there are some unusually attractive opportunities in this segment for patient investors.

On February 3, TD Cowen highlighted a new agreement between Salesforce Incorporated (NYSE:CRM) and the U.S. Army, extending access to additional Department of Defense users. According to the firm, the move opens Salesforce’s flexible IDIQ contract to a wider set of defense organizations, which “expands the potential TAM significantly.”

TD Cowen also stated that the Army has seen strong interest from other DoD groups, suggesting Salesforce products could see wider use across military operations. The update comes amid ongoing competition among major software providers for high-value government contracts.

Salesforce Incorporated (NYSE:CRM) is a cloud-based customer relationship management provider that connects individuals and companies across the globe through AI-driven applications and tools. Through its unified platform, it facilitates sales management, marketing services, and analytics. Some of its platforms include Agentforce, Data Cloud, Tableau, and Slack.

While we acknowledge the potential of CRM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 15 Most Promising Mid-Cap Healthcare Stocks Under $50 and 11 Most Promising Small-Cap Industrial Stocks Under $50.

Disclosure: None. This article is originally published at Insider Monkey.